Growth Metrics

ImmunityBio (IBRX) Operating Income Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn -8.32%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -8.32%
Dec 31, 2025 6.80%
Sep 30, 2025 30.68%
Jun 30, 2025 28.24%
Mar 31, 2025 32.32%
Dec 31, 2024 18.72%
Sep 30, 2024 -0.15%
Jun 30, 2024 -16.66%
Mar 31, 2024 14.68%
Dec 31, 2023 -0.58%
Sep 30, 2023 11.75%
Jun 30, 2023 -6.94%
Mar 31, 2023 -16.26%
Dec 31, 2022 -7.10%
Sep 30, 2022 -15.18%
Jun 30, 2022 7.31%
Mar 31, 2022 -11.25%
Dec 31, 2021 -156.67%
Sep 30, 2021 -19.67%
Jun 30, 2021 -68.72%
Mar 31, 2021 -135.04%
Dec 31, 2020 -91.71%
Sep 30, 2020 -310.07%
Jun 30, 2020 -194.38%
Mar 31, 2020 -100.17%
Dec 31, 2019 9.08%
Sep 30, 2019 33.36%
Jun 30, 2019 38.84%
Mar 31, 2019 35.18%
Dec 31, 2018 30.22%
Sep 30, 2018 1.37%
Jun 30, 2018 -18.72%
Mar 31, 2018 -11.07%
Dec 31, 2017 -1.00%
Sep 30, 2017 25.42%
Jun 30, 2017 31.87%
Mar 31, 2017 19.46%
Dec 31, 2016 15.97%
Sep 30, 2016 29.45%
Jun 30, 2016 73.19%
Mar 31, 2016 1.51%
Dec 31, 2015 -1,036.89%
Sep 30, 2015 -4,955.17%
Jun 30, 2015 -10,784.39%
Mar 31, 2015 -3,786.32%